The abstract is read at the publisher; the summary is JClub's.
AdhE, a gut microbial aldehyde-alcohol dehydrogenase from Eubacterium enriched in low metformin responders, degrades metformin into pharmacologically inactive products, reducing drug exposure.
- Why it matters: Metformin response varies widely in type 2 diabetes, and it was unclear whether gut microbes directly inactivate the drug to limit efficacy.
- What they did: The study identified AdhE in Eubacterium linked to low response, then used AdhE genetic deletion or phage-mediated depletion of AdhE-producing Eubacterium hallii MD1 in mice to test effects on exposure and glycemic control.
- The result: In mice, removing AdhE restored metformin exposure and glycemic control, and an AI-guided screen found daidzein as an AdhE inhibitor that blocked degradation and improved responsiveness.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.